Zotero Mendeley EndNote BibTex Kaynak Göster

-

Yıl 2003, Cilt 34, Sayı 3, 5 - 8, 01.04.2003

Öz

-

Kaynakça

  • 1. Huang SJ,Cheng L,Lewin J,Fu YS. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic and physiologic endometria. Path Res 1991; 187: 487-95
  • 2. Gambrell RD, Bagnel CA, Green Blatt RB. Role of estrogen and progesterone in the etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 1983; 146: 696-707
  • 3. Carcangiu ML, Chambers JT, Vaynick IM, Pirro M, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94:247-54
  • 4. Creasman WT, Soper JT, McCarty KS Jr, McCarty KS SR, Hinshaw W, Clarke-Pearson DL. Influence of cytoplasmic steroid receptor conteent on prognosis of early stage endometrial carcinoma. Am J Obatet Gynecol 1985; 151: 922-32
  • 5. Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA. The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol 1988; 72: 388-93
  • 6. Snijders MP, De Goeij AF, Koudstal J, Rousch MJ, Scheres HM, Stot JE, Bosnian FT. Is immunohistochemical analysis of estrogen and progesterone receptors in endometrial carcinoma superior to the radioligand binding assay? J Pathol 1990; 161: 129-35
  • 7. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993; 71(4 Suppl): 1467-70
  • 8. Vecek N, Nola M, Marusic et al. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1994; 73: 730-3
  • 9. Konski AA, Domenico D, Irving D et al. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging and estrogen/progesterone receptor status in endometrial adenocarcinoma. Am J Clin Oncol 1996; 19: 164-8
  • 10. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5
  • 11. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association of steroid hormone receptor expression eith low angiogenesis and bcl-2 expression. VircowsArch 2001; 438: 470-7
  • 12. Brustein S, Fructer R, Greene GL, Pertschuk LP. Immunocytochemical assay of progesterone receptors in paraffin embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Mod Pathol 1989; 2: 449- 55
  • 13. Bergeron C, Ferenzy A, Toft DO, Shyamala G. Immunocytochemical study of receptors in hyperplastic and neoplastic endometrial tissues. Cancer Res. 1988; 48: 6132-6. 14. Snijders MP, de Goeij AF, Koudstaal J, Thunriissen EB, de Haan J, Bosman FT. Oestrogen and progesterone receptor imunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 1992; 166: 171-7
  • 15. Papadimitriou CS, Athanasiadou S, Stylianidou A, Bai MK, Demoliatis J, Stehanou DG. Immunohistochemical detection of estrogen receptors on paraffin sections of normal, hyperplastic and carcinomatous endometrium. Oncol 1992; 49: 196-202.

Estrogen and progesterone expression in endometrial hyperplasia and carcinoma

Yıl 2003, Cilt 34, Sayı 3, 5 - 8, 01.04.2003

Öz

Objective: To evaluate estrogen and progesteron receptor expression in endometrial hyperplasia and carcinoma . Material and Method: In parafin-embedded specimens from 28 patients with endometrial hyperplasia and from 29 patients with endometrial carcinoma , estrogen and progesterone receptors were analysed by immunohistochemical method Results: Estrogen receptor expression was identified 71,4%(20/28) in endometrialhyperplasias and 17,2%(5/29) in endometrial carcinomas(p

Kaynakça

  • 1. Huang SJ,Cheng L,Lewin J,Fu YS. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic and physiologic endometria. Path Res 1991; 187: 487-95
  • 2. Gambrell RD, Bagnel CA, Green Blatt RB. Role of estrogen and progesterone in the etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 1983; 146: 696-707
  • 3. Carcangiu ML, Chambers JT, Vaynick IM, Pirro M, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94:247-54
  • 4. Creasman WT, Soper JT, McCarty KS Jr, McCarty KS SR, Hinshaw W, Clarke-Pearson DL. Influence of cytoplasmic steroid receptor conteent on prognosis of early stage endometrial carcinoma. Am J Obatet Gynecol 1985; 151: 922-32
  • 5. Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA. The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol 1988; 72: 388-93
  • 6. Snijders MP, De Goeij AF, Koudstal J, Rousch MJ, Scheres HM, Stot JE, Bosnian FT. Is immunohistochemical analysis of estrogen and progesterone receptors in endometrial carcinoma superior to the radioligand binding assay? J Pathol 1990; 161: 129-35
  • 7. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993; 71(4 Suppl): 1467-70
  • 8. Vecek N, Nola M, Marusic et al. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1994; 73: 730-3
  • 9. Konski AA, Domenico D, Irving D et al. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging and estrogen/progesterone receptor status in endometrial adenocarcinoma. Am J Clin Oncol 1996; 19: 164-8
  • 10. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5
  • 11. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association of steroid hormone receptor expression eith low angiogenesis and bcl-2 expression. VircowsArch 2001; 438: 470-7
  • 12. Brustein S, Fructer R, Greene GL, Pertschuk LP. Immunocytochemical assay of progesterone receptors in paraffin embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Mod Pathol 1989; 2: 449- 55
  • 13. Bergeron C, Ferenzy A, Toft DO, Shyamala G. Immunocytochemical study of receptors in hyperplastic and neoplastic endometrial tissues. Cancer Res. 1988; 48: 6132-6. 14. Snijders MP, de Goeij AF, Koudstaal J, Thunriissen EB, de Haan J, Bosman FT. Oestrogen and progesterone receptor imunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 1992; 166: 171-7
  • 15. Papadimitriou CS, Athanasiadou S, Stylianidou A, Bai MK, Demoliatis J, Stehanou DG. Immunohistochemical detection of estrogen receptors on paraffin sections of normal, hyperplastic and carcinomatous endometrium. Oncol 1992; 49: 196-202.

Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu

Yıl 2003, Cilt 34, Sayı 3, 5 - 8, 01.04.2003

Öz

Amaç: Endometrial hiperplazi ve karsinomlarda Östrojen ve progesteron ekşpresyonlarını değerlendirmek. Materyal ve Metod : 28 adet endometrial hiperplazi ve 29 adet endometrial karsinom içeren parafin blokda immunhistokimyasal yöntemle Östrojen ve progesteron reseptörleri çalışıldı. Bulgular : Endometrial hiperplazili olguların % 71.4'ünde (20/28), endometrialkarsinomlu olguların % 17.2'sinde (5/29) Östrojen reseptör ekspresyonu saptandı (p

Kaynakça

  • 1. Huang SJ,Cheng L,Lewin J,Fu YS. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic and physiologic endometria. Path Res 1991; 187: 487-95
  • 2. Gambrell RD, Bagnel CA, Green Blatt RB. Role of estrogen and progesterone in the etiology and prevention of endometrial cancer: review. Am J Obstet Gynecol 1983; 146: 696-707
  • 3. Carcangiu ML, Chambers JT, Vaynick IM, Pirro M, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94:247-54
  • 4. Creasman WT, Soper JT, McCarty KS Jr, McCarty KS SR, Hinshaw W, Clarke-Pearson DL. Influence of cytoplasmic steroid receptor conteent on prognosis of early stage endometrial carcinoma. Am J Obatet Gynecol 1985; 151: 922-32
  • 5. Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA. The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol 1988; 72: 388-93
  • 6. Snijders MP, De Goeij AF, Koudstal J, Rousch MJ, Scheres HM, Stot JE, Bosnian FT. Is immunohistochemical analysis of estrogen and progesterone receptors in endometrial carcinoma superior to the radioligand binding assay? J Pathol 1990; 161: 129-35
  • 7. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993; 71(4 Suppl): 1467-70
  • 8. Vecek N, Nola M, Marusic et al. Prognostic value of steroid hormone receptors concentration in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1994; 73: 730-3
  • 9. Konski AA, Domenico D, Irving D et al. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging and estrogen/progesterone receptor status in endometrial adenocarcinoma. Am J Clin Oncol 1996; 19: 164-8
  • 10. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5
  • 11. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association of steroid hormone receptor expression eith low angiogenesis and bcl-2 expression. VircowsArch 2001; 438: 470-7
  • 12. Brustein S, Fructer R, Greene GL, Pertschuk LP. Immunocytochemical assay of progesterone receptors in paraffin embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Mod Pathol 1989; 2: 449- 55
  • 13. Bergeron C, Ferenzy A, Toft DO, Shyamala G. Immunocytochemical study of receptors in hyperplastic and neoplastic endometrial tissues. Cancer Res. 1988; 48: 6132-6. 14. Snijders MP, de Goeij AF, Koudstaal J, Thunriissen EB, de Haan J, Bosman FT. Oestrogen and progesterone receptor imunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 1992; 166: 171-7
  • 15. Papadimitriou CS, Athanasiadou S, Stylianidou A, Bai MK, Demoliatis J, Stehanou DG. Immunohistochemical detection of estrogen receptors on paraffin sections of normal, hyperplastic and carcinomatous endometrium. Oncol 1992; 49: 196-202.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Gözde KIR Bu kişi benim


Handan ÇETİNER Bu kişi benim


Ayşe GÜRBÜZ Bu kişi benim

Yayımlanma Tarihi 1 Nisan 2003
Yayınlandığı Sayı Yıl 2003, Cilt 34, Sayı 3

Kaynak Göster

Bibtex @ { zktipb236762, journal = {Zeynep Kamil Tıp Bülteni}, issn = {1300-7971}, eissn = {2148-4864}, address = {}, publisher = {Zeynep Kamil Kadın ve Çocuk Hastalıkları EAH}, year = {2003}, volume = {34}, pages = {5 - 8}, doi = {10.16948/zktb.76391}, title = {Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu}, key = {cite}, author = {Kır, Gözde and Çetiner, Handan and Gürbüz, Ayşe} }
APA Kır, G. , Çetiner, H. & Gürbüz, A. (2003). Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu . Zeynep Kamil Tıp Bülteni , 34 (3) , 5-8 . Retrieved from https://dergipark.org.tr/tr/pub/zktipb/issue/22049/236762
MLA Kır, G. , Çetiner, H. , Gürbüz, A. "Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu" . Zeynep Kamil Tıp Bülteni 34 (2003 ): 5-8 <https://dergipark.org.tr/tr/pub/zktipb/issue/22049/236762>
Chicago Kır, G. , Çetiner, H. , Gürbüz, A. "Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu". Zeynep Kamil Tıp Bülteni 34 (2003 ): 5-8
RIS TY - JOUR T1 - Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu AU - Gözde Kır , Handan Çetiner , Ayşe Gürbüz Y1 - 2003 PY - 2003 N1 - DO - T2 - Zeynep Kamil Tıp Bülteni JF - Journal JO - JOR SP - 5 EP - 8 VL - 34 IS - 3 SN - 1300-7971-2148-4864 M3 - UR - Y2 - 2021 ER -
EndNote %0 Zeynep Kamil Tıp Bülteni Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu %A Gözde Kır , Handan Çetiner , Ayşe Gürbüz %T Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu %D 2003 %J Zeynep Kamil Tıp Bülteni %P 1300-7971-2148-4864 %V 34 %N 3 %R %U
ISNAD Kır, Gözde , Çetiner, Handan , Gürbüz, Ayşe . "Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu". Zeynep Kamil Tıp Bülteni 34 / 3 (Nisan 2003): 5-8 .
AMA Kır G. , Çetiner H. , Gürbüz A. Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu. Zeynep Kamil Tıp Bülteni. 2003; 34(3): 5-8.
Vancouver Kır G. , Çetiner H. , Gürbüz A. Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu. Zeynep Kamil Tıp Bülteni. 2003; 34(3): 5-8.
IEEE G. Kır , H. Çetiner ve A. Gürbüz , "Endometrial hiperplazi ve karsinomlarda östrojen ve progesteron reseptür ekspresyonu", Zeynep Kamil Tıp Bülteni, c. 34, sayı. 3, ss. 5-8, Nis. 2003, doi:10.16948/zktb.76391